GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (TSE:4528) » Definitions » Cyclically Adjusted Price-to-FCF

Ono Pharmaceutical Co (TSE:4528) Cyclically Adjusted Price-to-FCF : (As of May. 12, 2025)


View and export this data going back to 1963. Start your Free Trial

What is Ono Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ono Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Ono Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.76 56.60 34.40 24.98 13.65

Ono Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.98 21.79 17.58 14.45 13.65

Competitive Comparison of Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Ono Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Ono Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Ono Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=79.533/111.1000*111.1000
=79.533

Current CPI (Mar. 2025) = 111.1000.

Ono Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -5.066 98.400 -5.720
201509 -1.323 98.500 -1.492
201512 -5.409 98.100 -6.126
201603 9.457 97.900 10.732
201606 -13.744 98.100 -15.565
201609 26.334 98.000 29.854
201612 21.053 98.400 23.770
201703 61.389 98.100 69.524
201706 -49.362 98.500 -55.676
201709 3.193 98.800 3.591
201712 -13.587 99.400 -15.186
201803 33.574 99.200 37.602
201806 9.048 99.200 10.133
201809 28.594 99.900 31.800
201812 11.414 99.700 12.719
201903 23.239 99.700 25.896
201906 -0.717 99.800 -0.798
201909 42.379 100.100 47.036
201912 20.581 100.500 22.752
202003 40.944 100.300 45.353
202006 13.510 99.900 15.025
202009 36.588 99.900 40.690
202012 15.264 99.300 17.078
202103 42.177 99.900 46.906
202106 0.923 99.500 1.031
202109 62.649 100.100 69.534
202112 -29.247 100.100 -32.461
202203 66.048 101.100 72.581
202206 60.010 101.800 65.492
202209 94.750 103.100 102.102
202212 60.298 104.100 64.353
202303 82.088 104.400 87.356
202306 -35.588 105.200 -37.584
202309 93.421 106.200 97.731
202312 49.124 106.800 51.102
202403 80.456 107.200 83.383
202406 -4.174 108.200 -4.286
202409 67.890 108.900 69.262
202412 15.153 110.700 15.208
202503 79.533 111.100 79.533

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ono Pharmaceutical Co  (TSE:4528) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Ono Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Ono Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a world-wide business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co Headlines

No Headlines